CXMT memory progress claims trigger global chip stock sell-off

CXMT announcement rattles memory market

Shares tied to semiconductors and AI computing infrastructure fell across several markets on Tuesday after Chinese memory manufacturer ChangXin Memory Technologies, known as CXMT, said it had made progress on a new memory architecture. The company said its work could raise memory density by fitting more data into a smaller physical area. Investors interpreted the announcement as a possible sign that CXMT may be narrowing part of the technological gap with the global memory industry’s established leaders.

The reaction extended beyond one company or one exchange. Memory makers, chip equipment suppliers and companies exposed to the AI investment cycle all came under pressure. The move also arrived during a period of heightened concern about the scale of spending on AI infrastructure, much of it financed through heavy capital investment and, in some cases, debt.

A claim centred on denser DRAM

CXMT said over the weekend that it had made headway on a new architecture intended to increase memory density. According to CNBC, the company is reportedly planning to introduce a server-memory product based on the new cell architecture by the end of 2026. The design uses so-called “4F square” technology, an approach also pursued by SK Hynix, which presented a related development roadmap in 2025.

DRAM is important for AI systems because it stores data used by other processors during calculations. High-bandwidth memory is especially significant in advanced AI chip systems, and it is one of the areas where CXMT has been seen by analysts as trailing Micron, Samsung and SK Hynix. The company’s announcement does not establish that it has matched those competitors at the leading edge, but it was enough to alter investor perceptions of their market advantages.

CXMT is China’s leading domestic challenger to the major global memory manufacturers. Its position has gained visibility since its initial public offering in Shanghai in July. The company rose nearly 466% in its STAR Market debut, according to CNBC, becoming the most valuable China-listed company at that time.

Sharp moves in Asia and the United States

The immediate market response was broad. CNBC reported that Micron fell 3.62% on Tuesday, while SK Hynix’s South Korea-listed shares closed 10% lower and Samsung Electronics declined 7.4%. The Guardian reported a larger 4.8% decline for Micron in early Wall Street trading, illustrating that quoted moves can differ depending on the market snapshot and timing used.

Other memory-linked companies also weakened. SanDisk, Seagate and Western Digital slipped, according to CNBC. In Japan, Tokyo Electron fell 7.15%, while SoftBank Group, an OpenAI investor, lost 8.5%, according to The Guardian. Taiwan’s stock exchange fell by almost 2%, with TSMC down by a similar amount. Japan’s Nikkei declined 1.8%.

• SK Hynix closed down 10% in South Korea, according to CNBC and The Guardian.
• Samsung Electronics fell 7.4% on the South Korean exchange, according to both reports.
• South Korea’s Kospi index dropped 6.25%, according to The Guardian.
• The Nasdaq fell more than 100 points, or 0.35%, to 30,556 after the opening, The Guardian reported.

The declines were not limited to memory producers. Advanced Micro Devices was down 1.4%, Nvidia lost 0.8%, and Broadcom slipped 0.2% in early Wall Street trading, according to The Guardian. At the same time, the Dow Jones Industrial Average rose nearly 0.4% in early trading, showing that the selling pressure was concentrated in technology and semiconductor-related names rather than spread evenly across the entire market.

CXMT’s expanding market position

CXMT had been little known outside China before its summer listing. Its stock has since declined 4% from its IPO-day price of 49 yuan, CNBC reported, but its market capitalisation remained 3.46 trillion yuan, or about $520 billion. That compared with Tencent’s 3.87 trillion yuan in the same report.

The company, founded in 2016 and headquartered in Hefei, has reportedly increased its global DRAM market share. An HSBC note cited by CNBC estimated CXMT’s share at around 10%, up from about 4% one year earlier. That reported gain matters because even a company still regarded as behind the technological frontier can influence pricing expectations, customer choices and the perceived durability of competitors’ margins.

CXMT still faces important constraints. US export controls have effectively barred China from obtaining some advanced chipmaking equipment, including ASML’s extreme ultraviolet lithography machines, which are needed for the most advanced semiconductors. These restrictions remain a significant obstacle to the company’s effort to compete at the highest end of the memory market.

AI spending fears add to the pressure

The sell-off also reflected broader unease about the economics of AI. The Guardian reported that Broadcom chief executive Hock Tan told a conference in Singapore that many AI investors did not fully understand what they were buying and were setting extreme expectations. His comments followed months in which AI-related shares have moved sharply amid concerns about costly infrastructure build-outs.

Tan said OpenAI’s annualised revenue of $50 billion at the end of September suggested a viable business model, according to The Guardian, while offering no assurance of long-term profitability. He also noted that OpenAI remained loss-making because of heavy spending on training. These observations were not directed specifically at CXMT, but they reinforced a market environment in which investors were already reassessing optimistic assumptions around AI demand.

For companies and organisations planning AI infrastructure in English-speaking markets, the immediate change is not a proven replacement of established memory suppliers. It is a stronger reason to monitor memory availability, supplier concentration, procurement terms and the pace of competition. CXMT’s claims may increase pressure on established vendors, but the reported technical progress, market-share estimates and product plans should still be assessed separately from demonstrated commercial performance.